| HOME >> BIOLOGY >> TECHNOLOGY |
EL SEGUNDO, Calif., July 27 /PRNewswire/ -- NASA has exercised a $201 million second option on a contract with Wyle to provide continuing support to the Space Life Sciences Directorate at NASA's Johnson Space Center. The option extends the contract to April 30, 2013. The work will be done by Wyle's Integrated Science and Engineering Group, headquartered in Houston.
Under the bioastronautics contract, Wyle's work supports the International Space Station, space shuttle, Constellation and Human Research Programs. Wyle maintains readiness of Space Life Sciences facilities and laboratories.
Wyle provides services for program integration; habitability and environmental factors; human adaptation and countermeasures; space medicine; flight hardware development and human research activities.
Option 2 is a continuation of previous work with the exception that the space shuttle will be retired and no longer supported.
The majority of the work is performed at Johnson Space Center. Work also is performed at launch and landing sites in the United States and Russia, as well as at the University of Texas Medical Branch at Galveston and the Gagarin Cosmonaut Training Center in Moscow.
The contract's base period was from May 1, 2003 to April 30, 2008. Exercising Option 1 in July 2007 extended the contract to April 30, 2011. The base period and Option 1 have a combined value of $775 million. Exercising Option 2 brings the total potential value of the contract to $976 million.
Wyle, a privately held company, is a leading provider of high tech aerospace engineering and information technology services to the federal government on long-term outsourcing contracts. The company also provides life sciences services for NASA's astronaut corps as well as mission critical support services and space simulation; test and evaluation of aircraft, weapon
'/>"/>
| SOURCE Wyle Copyright©2009 PR Newswire. All rights reserved |
Related biology technology :
1. GeneThera Extends its Reach Overseas
2. Insmed Announces That NASDAQ Further Extends Temporary Suspension of Minimum Bid Closing Price Rule
3. Endo Pharmaceuticals Extends Subsequent Offering Period for Indevus Shares Until 5:00 pm EDT on Wednesday, March 18, 2009
4. BVF Acquisition LLC Extends Avigen Tender Offer to April 3, 2009
5. BVF Acquisition LLC Extends Avigen Tender Offer to March 6, 2009
6. BioMed Realty Trust Extends Leases With Vertex Pharmaceuticals Through 2015
7. GlaxoSmithKline Reduces Minimum Tender Condition and Extends Tender Offer To Acquire Genelabs Technologies, Inc.
8. GlaxoSmithKline Extends Tender Offer for Genelabs Technologies, Inc.
9. NASDAQs Temporary Suspension of Minimum Bid Closing Price Rules Extends Insmeds Compliance Date to March 20, 2009
10. Ziehm Imaging Extends its Training Offer
11. Gores Legacy of Innovation Extends From Products to Processes
| Copyright © 2003-2012 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |